In diabetes patients, the stroke-preventing benefits of bringing systolic blood pressure below 130 mmHg may be offset by an increased risk of cardiac events.…
Read More »Yearly Archives: 2012
Electronic Health Records Improve Care for Type 2 Diabetes Patients
Use of electronic health records shows promise for improving care and outcomes in patients with type 2 diabetes, but still has considerable room for improvement….
Read More »Pollution Tied to Diabetes and Hypertension Risk
In a study of more than 4,000 black women in Los Angeles, those who lived in areas with higher levels of traffic-related air pollution were at increased risk of diabetes and hypertension….
Read More »Efficacy and Safety of Bydureon Versus Metformin, Pioglitazone, and Sitagliptin as Monotherapy
In a once weekly injection of exenatide for Drug-Naive Patients with Type 2 Diabetes (DURATION-4) in a 26-week double-blind study they found that exenatide once weekly (EQW) was noninferior to metformin (MET) but not pioglitazone (PIO) and superior to sitagliptin (SITA) with regard to HbA1c reduction at 26 weeks….
Read More »Obesity Drug to Get Broader Label
Vivus Inc said the FDA has asked the company to remove a contraindication in the proposed label of its obesity drug Qnexa, a move that could help it reach a broader patient population.…
Read More »Obesity Diagnosis May Depend on Medical Professionals Weight
The study findings indicate that medical professionals with normal BMI more frequently reported discussing weight loss with patients than overweight or obese medical professionals….
Read More »New Predictors May Determine Metabolic Risk in Kids on Atypicals
Two new studies from a team of investigators suggest two possible predictors for the development of metabolic syndrome in children prescribed second-generation antipsychotics (SGAs)….
Read More »A Cost Comparison of a Basal-Bolus Regimen Vs. Premixed Insulin in Type 2’s
The study investigated the comparative costs of two different insulin regimens in type 2 diabetes based on data from the GINGER study, which investigated the efficacy and safety of an intensified insulin regimen.…
Read More »Editor’s Note: Special Edition – Weight Loss
As the month of January draws to a close it is that time when New Year’s Resolutions start to unravel. Many of our patients tried the newest fad diet or exercise program for a whopping 30 days and when they didn’t get the results that the TV commercials promised decided …
Read More »Letter from the Editor #610
Steve and I are constantly going to physician offices to talk about in-office diabetes education and the value for patients of coming in for monthly classes or group appointments. We even spent three months last summer giving you the tools to set up these programs in your office and get …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.